• LAST PRICE
    3.8000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 3.8000
  • Day Range
    ---
  • 52 Week Range
    Low 0.7500
    High 4.3400
  • Volume
    70

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table
TimeVolumeBSEM
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBSEM
Biostem Technologies Inc
42.0M
-29.7x
---
United StatesAPM
Aptorum Group Ltd
42.8M
-1.6x
---
United StatesEDXC
Endexx Corp
39.8M
-6.4x
---
United StatesGBLP
Global Pharmatech Inc
55.3M
-2.1x
---
United StatesADMP
Adamis Pharmaceuticals Corp
40.5M
-1.0x
---
United StatesODTC
Odonate Therapeutics Inc
45.5M
-0.6x
---
As of 2022-10-02

Company Information

Biostem Technologies, Inc. is an innovator, which is focused on harnessing the natural properties of perinatal tissue in the development, manufacturing and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products through its BioRetain processing method. BioRetain has been developed by applying the research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. The Company’s portfolio of brands includes VENDAJE, VENDAJE AC and VENDAJE OPTIC. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is a structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds.

Contact Information

Headquarters
2836 Center Port CirPOMPANO BEACH, FL, United States 33064-2136
Phone
954-380-8342
Fax
---

Executives

President, Chief Executive Officer, Director
Marc Barhonovich
Chief Financial Officer, Secretary, Treasurer, Director
Leon Willis
Chief Medical Officer
Dave Woynarowski
Director
Jennie Sandqvist
Director
Andrew VanVurst

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$42.0M
Revenue (TTM)
$7.4M
Shares Outstanding
11.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.77
EPS
$-0.13
Book Value
$-0.58
P/E Ratio
-29.7x
Price/Sales (TTM)
5.7
Price/Cash Flow (TTM)
---
Operating Margin
-11.01%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.